4Mayerl C, Lukasser M, Sedivy R, et al. Athemsclerosis research from past to present-on the track of two pathologists with oppo- sing views, Carl yon Rokitansky and Rudolf Vircbow [ J ]. Vir- chows Arch ,2006,449( 1 ) :96 - 103.
5Garzetti L,Menon R,Finardi A,et al. Activated macrophages re- lease microvesicles containing polarized M1 or M2 mRNAs [ J]. J Leukoc Biol,2013 Dec 30. [ Epub ahead of print].
6Gordon S, Taylor PR. Monocyty and macrophage heterogeneity [J]. Nat Rev Immunol,2005,5: 953 -964.
7Arnold CE, Whyte CS, Gordon P, et al. A critical role for sup- pressor of cytokine signalling 3 in promoting M1 macrophage acti- vation and function in vitro and in vivo [ J ]. Immunology,2014, 141(1):96 -110.
8Devaraj S, Jialal I. C - reactive protein polarizes human macro- phages to an M1 phenotype and inhibits transformation to the M2 phenotype [ J ]. Arterioscler Thromb Vasc Biol, 2011,31 ( 6 ) : 1397 - 1402.
9Pena OM, Pistolic J, Raj D, et al. Endotoxin tolerance represents a distinctive state of alternative polarization ( M2 ) in human mononuclear cells [J]. J Immunol, 2011, 186 ( 12 ) : 7243 - 7254.
10Mia S, Wamecke A, Zhang XM, et al. An optimized protocol for human M2 macrophages using M -CSF and IL-4/IL- 10/TGF 13 yields a dominant immunosuppressive phenotype [J] Scand J Immunol,2014 Feb 12. [ Epub ahead of print] .
